FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2175123390> ?p ?o ?g. }

• W2175123390 endingPage "1008" @default.
• W2175123390 startingPage "997" @default.
• W2175123390 abstract "Endostatin has been considered a highly specific inhibitor of endothelial cell proliferation and/or migration. To explore the use of endostatin in antiangiogenic gene therapy, we generated a recombinant adenovirus, AdEndo, carrying the gene for mouse endostatin. Injection of 10(9) PFU of AdEndo resulted in a low but significant suppression (25%) of preestablished tumor growth in murine models involving murine Lewis lung carcinoma (LLC) and human breast cancer MDA-MB-231 tumors. Greater anticancer activity was observed when the same dose of AdEndo was injected into two other preestablished murine models involving C51 murine colon cancer and HT29 human colon cancer (55 and 47% tumor growth reduction, respectively). In vitro, endostatin derived from AdEndo-infected MRC-5 fibroblasts inhibited the growth of C51 and HT29 cell lines (72 and 61%, respectively). The extent of this inhibition was comparable to that observed in endothelial cells: 75% for microcapillary endothelial cell line HMEC-1, 52% for human dermal microvascular endothelial cells, 46% for human umbilical vein endothelial cells, and 67% for calf pulmonary arterial endothelial cells. Both endothelial and colon cancer cells showed a clear increase in cell apoptosis (4- to 5-fold for endothelial cells and 5- to 10-fold for colon cancer cells) and an accumulation in the G(1) phase of the cell cycle. This antiproliferative activity was not observed in other tumor cell lines: LLC, MDA-MB-231, murine colon adenocarcinoma MC38, human prostate cancer cell line DU145, and human breast cancer cell line CAL51. Taken together, these results provide evidence that, in addition to its antiangiogenic activity, endostatin exerts a direct anticancer action that appears to be restricted to some tumor cell lines. Thus, endostatin could be used in some colon cancer treatments and its clinical efficacy would depend on the response of tumor cells themselves." @default.
• W2175123390 created "2016-06-24" @default.
• W2175123390 creator A5013260560 @default.
• W2175123390 creator A5014068004 @default.
• W2175123390 creator A5015078046 @default.
• W2175123390 creator A5019116334 @default.
• W2175123390 creator A5020975986 @default.
• W2175123390 creator A5030663479 @default.
• W2175123390 creator A5037620088 @default.
• W2175123390 creator A5039895370 @default.
• W2175123390 creator A5056220279 @default.
• W2175123390 creator A5072610830 @default.
• W2175123390 date "2003-07-10" @default.
• W2175123390 modified "2023-10-18" @default.
• W2175123390 title "Endostatin Exhibits a Direct Antitumor Effect in Addition to Its Antiangiogenic Activity in Colon Cancer Cells" @default.
• W2175123390 cites W100836827 @default.
• W2175123390 cites W1501492534 @default.
• W2175123390 cites W1569373357 @default.
• W2175123390 cites W1579297325 @default.
• W2175123390 cites W186245066 @default.
• W2175123390 cites W1968431199 @default.
• W2175123390 cites W1970211701 @default.
• W2175123390 cites W1976451311 @default.
• W2175123390 cites W1989772702 @default.
• W2175123390 cites W1991472045 @default.
• W2175123390 cites W1991598333 @default.
• W2175123390 cites W2015809080 @default.
• W2175123390 cites W2021792345 @default.
• W2175123390 cites W2030821918 @default.
• W2175123390 cites W2037735458 @default.
• W2175123390 cites W2058873146 @default.
• W2175123390 cites W2059983738 @default.
• W2175123390 cites W2059992425 @default.
• W2175123390 cites W2067980906 @default.
• W2175123390 cites W2073308580 @default.
• W2175123390 cites W2081511696 @default.
• W2175123390 cites W2096056021 @default.
• W2175123390 cites W2102061082 @default.
• W2175123390 cites W2121415986 @default.
• W2175123390 cites W2122096535 @default.
• W2175123390 cites W2131798870 @default.
• W2175123390 cites W2140724459 @default.
• W2175123390 cites W2157786523 @default.
• W2175123390 cites W2172782937 @default.
• W2175123390 cites W3102812175 @default.
• W2175123390 cites W36400390 @default.
• W2175123390 cites W4249031617 @default.
• W2175123390 doi "https://doi.org/10.1089/104303403766682250" @default.
• W2175123390 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12869217" @default.
• W2175123390 hasPublicationYear "2003" @default.
• W2175123390 type Work @default.
• W2175123390 sameAs 2175123390 @default.
• W2175123390 citedByCount "68" @default.
• W2175123390 countsByYear W21751233902012 @default.
• W2175123390 countsByYear W21751233902014 @default.
• W2175123390 countsByYear W21751233902015 @default.
• W2175123390 countsByYear W21751233902016 @default.
• W2175123390 countsByYear W21751233902017 @default.
• W2175123390 countsByYear W21751233902018 @default.
• W2175123390 countsByYear W21751233902021 @default.
• W2175123390 crossrefType "journal-article" @default.
• W2175123390 hasAuthorship W2175123390A5013260560 @default.
• W2175123390 hasAuthorship W2175123390A5014068004 @default.
• W2175123390 hasAuthorship W2175123390A5015078046 @default.
• W2175123390 hasAuthorship W2175123390A5019116334 @default.
• W2175123390 hasAuthorship W2175123390A5020975986 @default.
• W2175123390 hasAuthorship W2175123390A5030663479 @default.
• W2175123390 hasAuthorship W2175123390A5037620088 @default.
• W2175123390 hasAuthorship W2175123390A5039895370 @default.
• W2175123390 hasAuthorship W2175123390A5056220279 @default.
• W2175123390 hasAuthorship W2175123390A5072610830 @default.
• W2175123390 hasConcept C121608353 @default.
• W2175123390 hasConcept C123012128 @default.
• W2175123390 hasConcept C126322002 @default.
• W2175123390 hasConcept C202751555 @default.
• W2175123390 hasConcept C203014093 @default.
• W2175123390 hasConcept C2776438761 @default.
• W2175123390 hasConcept C2777834122 @default.
• W2175123390 hasConcept C2777847059 @default.
• W2175123390 hasConcept C2779013556 @default.
• W2175123390 hasConcept C2779723316 @default.
• W2175123390 hasConcept C2780394083 @default.
• W2175123390 hasConcept C2781182431 @default.
• W2175123390 hasConcept C502942594 @default.
• W2175123390 hasConcept C526805850 @default.
• W2175123390 hasConcept C54355233 @default.
• W2175123390 hasConcept C55493867 @default.
• W2175123390 hasConcept C62112901 @default.
• W2175123390 hasConcept C71924100 @default.
• W2175123390 hasConcept C75920679 @default.
• W2175123390 hasConcept C81885089 @default.
• W2175123390 hasConcept C86803240 @default.
• W2175123390 hasConcept C96232424 @default.
• W2175123390 hasConceptScore W2175123390C121608353 @default.
• W2175123390 hasConceptScore W2175123390C123012128 @default.
• W2175123390 hasConceptScore W2175123390C126322002 @default.
• W2175123390 hasConceptScore W2175123390C202751555 @default.
• W2175123390 hasConceptScore W2175123390C203014093 @default.

• next